• Topic
• Cancer >> Lung Cancer >> Biological therapies for lung cancer >> Biological therapies for lung cancer

Biological therapies for lung cancer

• >> Lung Cancer >> Biological therapies for lung cancer >> Biological therapies for lung cancer

Biological therapies for lung cancer

• >> Lung Cancer >> Biological therapies for lung cancer >> Biological therapies for lung cancer

Biological therapies for lung cancer

• Clip
• Cancer >> Lung Cancer >> aged 71-81 >> Doris - Interview 49 >> Doris is taking a three month course of gefitinib. She takes tablets every morning. Apart from losing a little hair she has not had side effects.

Doris developed a cough and went to the doctor. A scan revealed a shadow on both her lungs, which turned out to be adenocarcinoma. She had part of her right lung removed by video assisted thoracic surgery (VATS) and has been taking Gefitinib.

• Cancer >> Lung Cancer >> Aged 61-70 >> Sue - Interview 47 >> Sue was told that she could either have more chemotherapy or start the biological therapy erlotinib (Tarceva).

Sue was diagnosed with lung cancer in 2008. She had 4 cycles of chemotherapy, which was effective, but had bad side effects. When the tumour grew again in 2009 she started a biological therapy, erlotinib (Tarceva) with good results, and is still having it.

• Cancer >> Lung Cancer >> Aged 61-70 >> Sue - Interview 47 >> Soon after starting erlotinib (Tarceva) Sue had various side effects, including a skin rash.

Sue was diagnosed with lung cancer in 2008. She had 4 cycles of chemotherapy, which was effective, but had bad side effects. When the tumour grew again in 2009 she started a biological therapy, erlotinib (Tarceva) with good results, and is still having it.

• Cancer >> Lung Cancer >> Aged 61-70 >> Sue - Interview 47 >> Other side effects that Sue experienced included frizzy hair, poor nails, dry skin, sore itchy eyes and occasional diarrheoa. She found many products

Sue was diagnosed with lung cancer in 2008. She had 4 cycles of chemotherapy, which was effective, but had bad side effects. When the tumour grew again in 2009 she started a biological therapy, erlotinib (Tarceva) with good results, and is still having it.

• Cancer >> Lung Cancer >> Aged 61-70 >> Sue - Interview 47 >> Sue is glad that she decided to have one of the biological therapies. She has been taking erlotinib (Tarceva) for over a year and it is still working

Sue was diagnosed with lung cancer in 2008. She had 4 cycles of chemotherapy, which was effective, but had bad side effects. When the tumour grew again in 2009 she started a biological therapy, erlotinib (Tarceva) with good results, and is still having it.

• Cancer >> Lung Cancer >> Aged 61-70 >> Sue - Interview 47 >> Sue has been well supported by her husband, family and friends. Erlotinb makes her tired but she still enjoys walks, holidays and outings.

Sue was diagnosed with lung cancer in 2008. She had 4 cycles of chemotherapy, which was effective, but had bad side effects. When the tumour grew again in 2009 she started a biological therapy, erlotinib (Tarceva) with good results, and is still having it.

• Cancer >> Lung Cancer >> Aged 61-70 >> Sue - Interview 47 >> Sue is aware that her treatment may cost the NHS a great deal of money because she will be taking it for as long as it is effective.

Sue was diagnosed with lung cancer in 2008. She had 4 cycles of chemotherapy, which was effective, but had bad side effects. When the tumour grew again in 2009 she started a biological therapy, erlotinib (Tarceva) with good results, and is still having it.